Suscribirse

Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis - 11/08/23

Doi : 10.1016/j.clinre.2023.102160 
Abdulrahman Ismaiel a, Blal El Hosiny b, Mohamed Ismaiel c, Daniel-Corneliu Leucuta d, , Stefan-Lucian Popa a, Cristina Sorina Catana e, Dan L. Dumitrascu a
a 2nd Department of Internal Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania 
b Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania 
c Cardiothoracic Surgery department, Royal Victoria Hospital, Belfast, United Kingdom 
d Department of Medical Informatics and Biostatistics, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania 
e Department of Medical Biochemistry, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania 

Corresponding author at: Department of Medical Informatics and Biostatistics, "Iuliu Hatieganu" University of Medicine and Pharmacy, 6 Pasteur Street, 400349 Cluj-Napoca, Romania.Department of Medical Informatics and BiostatisticsIuliu Hatieganu" University of Medicine and Pharmacy6 Pasteur StreetCluj-Napoca400349Romania

Highlights

WHtR is significantly increased in NAFLD patients compared to controls.
Compared to male NAFLD patients, female NAFLD patients present higher WHtR.
WHtR's accuracy in predicting NAFLD is considered acceptable in comparison to other presently suggested scores.
WHtR can be used in clinical practice as a simple non-invasive score to predict NAFLD.

El texto completo de este artículo está disponible en PDF.

Abstract

Background and Aims

Current nonalcoholic fatty liver disease (NAFLD) guidelines do not provide any recommendations regarding the waist-to-height ratio (WHtR), a simple obesity metric calculated by dividing waist circumference by height. Therefore, we performed a systematic review and meta-analysis aiming to evaluate WHtR in NAFLD.

Methods

We performed a systematic electronic search on PubMed, Embase, and Scopus, identifying observational studies assessing WHtR in NAFLD. QUADAS-2 tool was used to evaluate the quality of included studies. The two main statistical outcomes were the area under the curve (AUC) and the mean difference (MD).

Results

We included a total of 27 studies in our quantitative and qualitative synthesis, with a total population of 93,536 individuals. WHtR was significantly higher in NAFLD patients compared to controls with an MD of 0.073 (95% CI 0.058 - 0.088). This was also confirmed after conducting a subgroup analysis according to the hepatic steatosis diagnosis method, for ultrasound (MD 0.066 [96% CI 0.051 - 0.081]) and transient elastography (MD 0.074 [96% CI 0.053 – 0.094]). Moreover, NAFLD male patients presented significantly lower WHtR compared to female patients (MD -0.022 [95% CI -0.041 – -0.004]). The AUC of WHtR for predicting NAFLD was 0.815 (95% CI 0.780 – 0.849).

Conclusions

WHtR is considerably higher in NAFLD patients compared to controls. Female NAFLD patients present higher WHtR compared to NAFLD male patients. In comparison to other presently suggested scores and markers, the WHtR's accuracy in predicting NAFLD is considered acceptable.

El texto completo de este artículo está disponible en PDF.

Keywords : Non-alcoholic fatty liver disease (NAFLD), Metabolic-dysfunction-associated fatty liver disease (MAFLD), Hepatic steatosis, Non-invasive scores


Esquema


© 2023  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 47 - N° 7

Artículo 102160- août 2023 Regresar al número
Artículo precedente Artículo precedente
  • Factors associated with discordance in the assessment of fibrosis stage between transient elastography and liver biopsy in NAFLD patients
  • Meng Lu, Mingyu Zhu, Hu Li, Qingling Wang, Yuting Qian, Mingjie Wang, Li Chen
| Artículo siguiente Artículo siguiente
  • Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study
  • Jérôme Dumortier, Domitille Erard, François Villeret, François Faitot, Christophe Duvoux, Stéphanie Faure, Claire Francoz, Jean Gugenheim, Jean Hardwigsen, Jean-Baptiste Hiriart, Pauline Houssel-Debry, Arnaud Del Bello, Guillaume Lassailly, Claire Vanlemmens, Faouzi Saliba, Clara Altman, Marianne Latournerie, Sébastien Dharancy, Tarek Debs, Groupe de recherche français en Greffe de Foie (GReF2)

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.